Author
Listed:
- Fatemeh Mirzamohammadi
(Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School)
- Anastasia Kozlova
(Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School)
- Garyfallia Papaioannou
(Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School)
- Elena Paltrinieri
(Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School)
- Ugur M. Ayturk
(Musculoskeletal Integrity Program, Hospital for Special Surgery)
- Tatsuya Kobayashi
(Endocrine Unit, Massachusetts General Hospital, and Harvard Medical School)
Abstract
Feingold syndrome is a skeletal dysplasia caused by loss-of-function mutations of either MYCN (type 1) or MIR17HG that encodes miR-17-92 microRNAs (type 2). Since miR-17-92 expression is transcriptionally regulated by MYC transcription factors, it has been postulated that Feingold syndrome type 1 and 2 may be caused by a common molecular mechanism. Here we show that Mir17-92 deficiency upregulates TGF-β signaling, whereas Mycn-deficiency downregulates PI3K signaling in limb mesenchymal cells. Genetic or pharmacological inhibition of TGF-β signaling efficiently rescues the skeletal defects caused by Mir17-92 deficiency, suggesting that upregulation of TGF-β signaling is responsible for the skeletal defect of Feingold syndrome type 2. By contrast, the skeletal phenotype of Mycn-deficiency is partially rescued by Pten heterozygosity, but not by TGF-β inhibition. These results strongly suggest that despite the phenotypical similarity, distinct molecular mechanisms underlie the pathoetiology for Feingold syndrome type 1 and 2.
Suggested Citation
Fatemeh Mirzamohammadi & Anastasia Kozlova & Garyfallia Papaioannou & Elena Paltrinieri & Ugur M. Ayturk & Tatsuya Kobayashi, 2018.
"Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models,"
Nature Communications, Nature, vol. 9(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03788-7
DOI: 10.1038/s41467-018-03788-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03788-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.